OTC Prilosec
This article was originally published in The Tan Sheet
Executive Summary
Heartburn treatment should be available without a prescription by year-end, P&G CFO Clayton Daly says during Consumer Analyst Group of New York conference Feb. 22. "We're in ongoing discussions with FDA about labeling and dosing, and we believe we're moving in the right direction...in terms of getting that product approved later this year," he noted. P&G, which holds OTC marketing rights to AstraZeneca's Rx version, had predicted approval by July (1"The Tan Sheet" June 18, 2001, p. 6)...